Liz Savage

  • Citations Per Year
Learn More
  • Liz Savage
  • Journal of the National Cancer Institute
  • 2007
A new product on the market in a handful of U.S. cities has stirred up mixed feelings in the public-health community. Known as snus (rhymes with " goose "), it is a smokeless tobacco product that has been used in Sweden for nearly a century. Because it has lower levels of cancer-causing tox-ins than cigarettes or other smokeless tobacco products that are(More)
  • Liz Savage
  • Journal of the National Cancer Institute
  • 2009
that women should be clearly informed of these harms in order to make their own choice about whether to attend for screening.” Writing in the British Medical Journal , Peter Gotzsche, M.D., Dr.Med.Sci., director of the Nordic Cochrane Center in Copenhagen, and colleagues singled out the NHS and its breast cancer screening pamphlet as an example. The(More)
  • Liz Savage
  • Journal of the National Cancer Institute
  • 2007
A fter decades of searching for a replacement for prostate-specific antigen (PSA) in prostate cancer screening, many researchers are once again examining variations on the long-beleaguered biomarker. PSA has withstood years of skepticism from critics who blame it for the overdiag-nosis and overtreatment of millions of men since it became the favorite(More)
JCB • VOLUME 184 • NUMBER 1 • 2009 4 V ivek Malhotra fi rst began studying protein secretion in the late 1980s, and he has spent most of his career since then trying to unlock the secrets of secretion and in particular the organization of the Golgi complex. In doing so, Malhotra has developed a true passion for the scientifi c process. As a postdoc at(More)